Han‑Gins Indxx Healthcare Megatrend Equal Weight
(WELP)
£5.33
Previous business day’s close price
‑£0.66 (‑11.04%)
max available period
£4.79
£8.75
08 Apr 19
26 Apr 24
Details
This ETF aims to replicate the performance of the Indxx Global NextGen Healthcare index, offering exposure to companies at the cross‑roads of medicine and technology which are shaping the future of healthcare.
The index is offers exposure to 100 global companies from the following 10 sub‑themes: robotics; nanotechnology; genome sequencing; healthcare trackers; biological engineering; bioinformatics; neuroscience; medical devices; telemedicine and healthcare analytics.
The index is offers exposure to 100 global companies from the following 10 sub‑themes: robotics; nanotechnology; genome sequencing; healthcare trackers; biological engineering; bioinformatics; neuroscience; medical devices; telemedicine and healthcare analytics.
Key information
ETF Breakdown
Hims&Hers Health Inc
1.8%
ShockWave Medical Inc
1.7%
4D Molecular Therapeutics Inc
1.6%
Natera Inc
1.5%
Sarepta Therapeutics Inc
1.4%
Edwards Lifesciences Corp
1.3%
Telix Pharmaceuticals Limited
1.3%
Veeva Systems Inc
1.2%
Boston Scientific Corp.
1.2%
Intuitive Surgical Inc
1.2%
Align Technology, Inc.
1.2%
Supernus Pharmaceuticals Inc
1.2%
Ge Healthcare Technologies Inc
1.2%
Beam Therapeutics Inc
1.2%
Demant AS
1.2%
Procept BioRobotics Corp
1.2%
Regenxbio Inc
1.1%
Zur Rose Group AG
1.1%
Regeneron Pharmaceuticals, Inc.
1.1%
Neurocrine Biosciences, Inc.
1.1%
Resmed Inc.
1.1%
Dexcom Inc
1.1%
CRISPR Therapeutics AG
1.1%
Terumo Corporation
1.1%
West Pharmaceutical Services, Inc.
1.1%
Shop Apotheke Europe N.V.
1.1%
Sectra Ab (Publ
1.1%
Glaukos Corporation
1.1%
Cochlear Ltd.
1.1%
Zimmer Biomet Holdings Inc
1.1%
Hologic, Inc.
1.1%
Medtronic Plc
1.1%
iRhythm Technologies Inc
1.1%
Sosei Group Corp.
1.1%
Bio‑Rad Laboratories Inc.
1.1%
Phreesia Inc
1.1%
Arcturus Therapeutics Holdings Inc
1.1%
PeptiDream Inc.
1.1%
Lantheus Holdings Inc
1.0%
Agilent Technologies Inc.
1.0%
Myriad Genetics, Inc.
1.0%
Harmony Biosciences Holdings Inc
1.0%
Intra‑Cellular Therapies Inc
1.0%
Xenon Pharmaceuticals Inc
1.0%
Steris Plc
1.0%
Fisher&Paykel Healthcare Corporation Limited
1.0%
PTC Therapeutics Inc
1.0%
Recursion Pharmaceuticals Inc
1.0%
Merit Medical Systems, Inc.
1.0%
Straumann Holding AG
1.0%
Biomerieux
1.0%
Jazz Pharmaceuticals plc
1.0%
Globus Medical Inc
1.0%
Olympus Corp.
1.0%
Alkermes plc
1.0%
Illumina Inc
1.0%
Sysmex Corporation
1.0%
Qiagen N.V.
1.0%
Exact Sciences Corp.
1.0%
Diasorin S.p.A.
1.0%
Twist Bioscience Corp
0.9%
Elekta AB (publ)
0.9%
Smith&Nephew plc
0.9%
Biomarin Pharmaceutical Inc.
0.9%
Intellia Therapeutics Inc
0.9%
Neuren Pharmaceuticals Ltd
0.9%
Teleflex Incorporated
0.9%
Amicus Therapeutics Inc
0.9%
Sonova Holding AG
0.9%
Asahi Intecc Co. Ltd.
0.9%
BeiGene Ltd
0.9%
Ionis Pharmaceuticals Inc
0.9%
Koninklijke Philips N.V.
0.9%
Sage Therapeutics Inc
0.9%
Penumbra Inc
0.9%
SK bioscience Co. Ltd.
0.9%
Biogen Inc
0.9%
JMDC Inc.
0.8%
Yidu Tech Inc.
0.8%
Alnylam Pharmaceuticals Inc
0.8%
Health Catalyst Inc
0.8%
Veracyte Inc
0.8%
Insulet Corporation
0.8%
BioArctic AB
0.8%
Schrodinger Inc
0.8%
Neogenomics Inc.
0.8%
Alibaba Group Holding Ltd
0.8%
Alector Inc
0.8%
Inari Medical Inc
0.7%
Conmed Corp (Pre‑Merger)
0.7%
Teladoc Health Inc
0.7%
Shanghai MicroPort MedBot (Group) Co.Ltd.
0.7%
Ping An Healthcare And Technology Company Limited
0.7%
Lunit Inc
0.7%
10x Genomics Inc
0.7%
Prothena Corporation plc
0.7%
QuidelOrtho Corporation
0.7%
Shandong Weigao Group Medical Polymer Co. Ltd.
0.6%
Adaptive Biotechnologies Corp
0.6%
Acadia Pharmaceuticals Inc
0.6%
Others
< 0.1%
No holdings found.
Please try a different search.
Please try a different search.
North America
61.5%
Europe ex‑UK
14.7%
Japan
7.0%
Asia ex‑Japan
4.3%
Emerging Markets
2.1%
UK
2.0%
Rest of the World
8.4%
Industrial
30.9%
Healthcare
26.5%
Technology
9.8%
Financial
1.1%
Sector ‐ Other
31.6%
Why InvestEngine
Unbeatable value
Build your own portfolio commission free or leave it to our experts for just 0.25%.
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Choice of 620+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
